Report cover image

Asia Pacific Vaccines Market Size and Forecast (2021 - 2031)

Publisher The Insight Partners
Published Jan 14, 2026
SKU # TIP20949553

Description

The Asia Pacific Vaccines Market is projected to grow significantly, reaching approximately US$ 22,940.5 million by 2031, up from US$ 15,065.1 million in 2024, with an estimated compound annual growth rate (CAGR) of 6.2% from 2025 to 2031.

Executive Summary and Market Analysis

The Asia Pacific region has established itself as a prominent center for vaccine research and development, capitalizing on its cost-effectiveness, diverse population, and swift participant recruitment capabilities. The region plays a crucial role in global vaccine innovation, holding a substantial share of both prophylactic and therapeutic vaccine trials. According to Global Health Press, Asia Pacific leads globally with 46% of prophylactic vaccine trials and 31% of therapeutic trials, outpacing other regions in trial volume and operational efficiency.

Moreover, extensive public health initiatives and universal immunization objectives have led to increased vaccine coverage rates. The urgency for pandemic preparedness following COVID-19 has further spurred investments in research, development, and manufacturing capabilities. The region's advancing healthcare infrastructure and established cold chain logistics facilitate the effective storage and distribution of vaccines, even in remote locations.

Strategic Insights

Market Segmentation Analysis
  • By Type: The market is categorized into Conjugated Vaccines, Inactivated Vaccines, Live Vaccines, Recombinant Vaccines, and Toxoid Vaccines, with Conjugated Vaccines holding the largest market share in 2024.
  • By Indication: Segmented into HPV, PCV, DTP, Hepatitis, Influenza, Dengue, and others, with HPV leading in market share in 2024.
  • By Route of Administration: Divided into Injection, Oral, and Other, where the Injection segment dominates.
  • By Age Group: The market is split into Pediatric and Adult segments, with Pediatrics holding the largest share.
Market OutlookThe World Health Organization (WHO) has identified over 30 priority pathogens that pose risks for global public health emergencies, including influenza A, dengue, and monkeypox. The frequency of infectious disease outbreaks has risen, with many originating from animals or transmitted by vectors. As of May 11, 2025, SARS-CoV-2 activity has seen a resurgence, with a test positivity rate of 11% across 73 reporting countries, similar to the peak observed in July 2024.

In April 2024, the WHO reported over 7.6 million dengue cases, with 3.4 million confirmed and over 3,000 deaths. Additionally, a global mpox outbreak during 2022-2023 resulted in 87,000 cases and 140 deaths, prompting the WHO to declare it a Public Health Emergency of International Concern (PHEIC).

In 2022, approximately 254 million people were living with hepatitis B, and 50 million with hepatitis C, with a significant portion of those affected being children. Vaccination is a key preventive measure against hepatitis, and WHO aims to reduce new infections by 90% and deaths by 65% by 2030.

The demand for vaccines surges during outbreaks of contagious diseases, as seen during the COVID-19 pandemic, which created an unprecedented need for rapid immunization. WHO estimates that global immunization efforts have saved around 154 million lives over the past 50 years, with measles vaccination significantly reducing infant mortality.

Country Insights

The Asia Pacific Vaccines Market is further segmented by country, including China, Japan, India, Australia, South Korea, and others, with China holding the largest market share in 2024. China is poised to become a major supplier of affordable vaccines, having developed a robust vaccine manufacturing industry since the introduction of its expanded immunization program in 1978. The country produces a wide range of vaccines for both viral and bacterial diseases.

Innovations such as the first respiratory syncytial virus (RSV) prophylaxis for infants, Levitra/Beyfortus, are being introduced, with expectations for availability in 2024-2025. Chinese companies are also advancing mRNA vaccines and combination vaccines, reflecting a trend towards innovative vaccine technologies.

Company Profiles

Key players in the Asia Pacific Vaccines Market include Abbott Laboratories, GSK Plc, Pfizer Inc., Merck & Co. Inc., Novartis AG, Sanofi SA, CSL Ltd, Serum Institute of India Pvt Ltd, BioNTech SE, and Sinovac Biotech Ltd. These companies are pursuing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Vaccines Market Landscape
4.1 Market Overview
4.2 PEST Analysis
5. Asia Pacific Vaccines Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Vaccines Market - Asia Pacific Market Analysis
6.1 Asia Pacific Vaccines Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Vaccines Market Forecast and Analysis
7. Asia Pacific Vaccines Market Revenue Analysis - by Type
7.1 Conjugated
7.1.1 Overview
7.1.2 Conjugated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Inactivated
7.2.1 Overview
7.2.2 Inactivated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Live
7.3.1 Overview
7.3.2 Live: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Recomb
7.4.1 Overview
7.4.2 Recomb: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Toxoid
7.5.1 Overview
7.5.2 Toxoid: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. Asia Pacific Vaccines Market Revenue Analysis - by Indication
8.1 HPV
8.1.1 Overview
8.1.2 HPV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 PCV
8.2.1 Overview
8.2.2 PCV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DTP
8.3.1 Overview
8.3.2 DTP: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Hepatitis
8.4.1 Overview
8.4.2 Hepatitis: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6 Dengue
8.6.1 Overview
8.6.2 Dengue: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.7 Other
8.7.1 Overview
8.7.2 Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. Asia Pacific Vaccines Market Revenue Analysis - by Route Of Administration
9.1 Injection
9.1.1 Overview
9.1.2 Injection: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Other
9.3.1 Overview
9.3.2 Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. Asia Pacific Vaccines Market Revenue Analysis - by Age Group
10.1 Pediatric
10.1.1 Overview
10.1.2 Pediatric: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Adult
10.2.1 Overview
10.2.2 Adult: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. Asia Pacific Vaccines Market - Country Analysis
11.1 Asia Pacific
11.1.1 Asia Pacific Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.1.1 Asia Pacific Vaccines Market Revenue and Forecast and Analysis - by Country
11.1.2.2 China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.1.2.2.1 China: Asia Pacific Vaccines Market Share - by Type
11.1.2.2.2 China: Asia Pacific Vaccines Market Share - by Indication
11.1.2.2.3 China: Asia Pacific Vaccines Market Share - by Route Of Administration
11.1.2.2.4 China: Asia Pacific Vaccines Market Share - by Age Group
11.2.3.3 Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2.3.3.1 Japan: Asia Pacific Vaccines Market Share - by Type
11.2.3.3.2 Japan: Asia Pacific Vaccines Market Share - by Indication
11.2.3.3.3 Japan: Asia Pacific Vaccines Market Share - by Route Of Administration
11.2.3.3.4 Japan: Asia Pacific Vaccines Market Share - by Age Group
11.3.4.4 India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3.4.4.1 India: Asia Pacific Vaccines Market Share - by Type
11.3.4.4.2 India: Asia Pacific Vaccines Market Share - by Indication
11.3.4.4.3 India: Asia Pacific Vaccines Market Share - by Route Of Administration
11.3.4.4.4 India: Asia Pacific Vaccines Market Share - by Age Group
11.4.5.5 Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4.5.5.1 Australia: Asia Pacific Vaccines Market Share - by Type
11.4.5.5.2 Australia: Asia Pacific Vaccines Market Share - by Indication
11.4.5.5.3 Australia: Asia Pacific Vaccines Market Share - by Route Of Administration
11.4.5.5.4 Australia: Asia Pacific Vaccines Market Share - by Age Group
11.5.6.6 South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.5.6.6.1 South Korea: Asia Pacific Vaccines Market Share - by Type
11.5.6.6.2 South Korea: Asia Pacific Vaccines Market Share - by Indication
11.5.6.6.3 South Korea: Asia Pacific Vaccines Market Share - by Route Of Administration
11.5.6.6.4 South Korea: Asia Pacific Vaccines Market Share - by Age Group
11.6.7.7 Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.6.7.7.1 Rest of APAC: Asia Pacific Vaccines Market Share - by Type
11.6.7.7.2 Rest of APAC: Asia Pacific Vaccines Market Share - by Indication
11.6.7.7.3 Rest of APAC: Asia Pacific Vaccines Market Share - by Route Of Administration
11.6.7.7.4 Rest of APAC: Asia Pacific Vaccines Market Share - by Age Group
12 Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning & Concentration
13 Industry Landscape
13.1 Overview
13.2 New Product Development
13.3 Merger and Acquisition
13.4 Other Strategic Developments
14 COMPANY PROFILES
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GSK Plc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Pfizer Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Merck & Co Inc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Novartis AG
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Sanofi SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 CSL Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Serum Institute of India Pvt Ltd
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BioNTech SE
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sinovac Biotech Ltd
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Vaccines Market Segmentation
Table 2. List of Vendors
Table 3. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 5. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 6. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 7. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 8. Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 9. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 10. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 11. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 12. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 13. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 14. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 15. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 16. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 17. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 18. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 19. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 20. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 21. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 22. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 23. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 24. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 25. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 26. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 27. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 28. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 29. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
Table 30. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 31. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route Of Administration
Table 32. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 33. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Asia Pacific Vaccines Market Segmentation - Country
Figure 2. PEST Analysis
Figure 3. Ecosystem: Vaccines Market
Figure 4. Asia Pacific Vaccines Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Vaccines Market Revenue (US$ Million), 2024 - 2031
Figure 7. Asia Pacific Vaccines Market Share (%) - by Type, 2024 and 2031
Figure 8. Conjugated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Inactivated: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Live: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Recomb: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Toxoid: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Asia Pacific Vaccines Market Share (%) - by Indication, 2024 and 2031
Figure 14. HPV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. PCV: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. DTP: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Hepatitis: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Influenza: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Dengue: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Asia Pacific Vaccines Market Share (%) - by Route Of Administration, 2024 and 2031
Figure 22. Injection: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Oral: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Other: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Asia Pacific Vaccines Market Share (%) - by Age Group, 2024 and 2031
Figure 26. Pediatric: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Adult: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Asia Pacific Vaccines Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 29. China: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 30. Japan: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. India: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Australia: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 33. South Korea: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Rest of APAC: Asia Pacific Vaccines Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Company Positioning & Concentration

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us